Current treatment modalities for T2DM mainly focus on lowering blood glucose level via lifestyle modification or anti-diabetic drugs that stimulate insulin secretion from the pancreas or enhance the peripheral tissue sensitivity (Chatterjee et al., 2017). This evidence concerns the gene INS and type 2 diabetes mellitus.